×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
Vision
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
Vision
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: CuATSM (Copper(II)-diacetyl-bis(N4-methylthiosemicarbazone))
therapeutic
787 words
KG: CuATSM (Copper(II)-diacetyl-bis(N4-methylthiosemicarbazone))
2026-03-22
kind:therapeutic
section:therapeutics
state:published
Contents
CuATSM (Copper(II)-diacetyl-bis(N4-methylthiosemicarbazone))
💊
Therapeutic Info
Name
CuATSM (Copper(II)-diacetyl-bis(N4-methylthiosemicarbazone))
Summary
Page for CuATSM (Copper(II)-diacetyl-bis(N4-methylthiosemicarbazone))
Knowledge Graph
Related Hypotheses (2)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Microbial Inflammasome Priming Prevention
Score: 0.58
Related Analyses (3)
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Related Experiments (4)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40